GALDERMA GROUP AG reported a significant surge in first-quarter performance, with constant-currency sales climbing 25.5% to reach $1.47 billion. The Zug-based company, headquartered in Switzerland, attributed this growth largely to an exceptional performance in the United States, where revenue jumped 41.5% year-on-year during the January–March period.
Following the announcement, the company's shares rose by more than 6% in morning trading. The robust start to the year has allowed management to express increased confidence in navigating current market volatility and potential future trade hurdles.











